SingaporeOverview
Financial Performance
Business Operations & Assets
Business Details
Reason For Sale
Description
Once in a lifetime opportunity to invest early in one of the most exciting pharmaceutical companies offering the greatest medical breakthrough of the twenty first century.
Our Australian Company has spent years developing our product and we are now ready to mass market to the world.
Our product release announcement will make news headlines around the world. Projected sales in the USA are expected to exceed $30 million per month by the end of the year.
To help fund the growth of our company at this critical stage, we are offering the sale of up to 10% shareholding in our Company. Shareholders will Own part of the company and receive monthly dividends based on sales.
Minimum investment starts at $5,000
For more information about our company and our world leading product, please request our business brief.
Listing information is provided by the listing provider or their representatives and has not been independently verified by our platform. Users should verify all information and conduct their own due diligence before making any decision, payment or commitment.
All communications, agreements, transactions, disputes and claims are solely between the relevant parties.
Learn how to avoid scams